FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy ...Middle East

Medscape - News
FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis. Medscape Medical News

Hence then, the article about fda expands vutrisiran indication to attr cardiomyopathy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy )

Apple Storegoogle play

Last updated :

Also on site :